Top 34 Great Point Partners LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | 7.37% | 1.70M | $31.3M | -2.86%(-50.00K) | $27.55(-16.40%) | 2026-06-30 | |
| ABVX | ABIVAX SA | 6.41% | 204.3K | $27.2M | new | $39.56(+206.93%) | 2026-06-30 | |
| VERA | VERA THERAPEUTICS INC | 6.07% | 600.8K | $25.8M | +201.40%(+401.49K) | $42.14(-24.94%) | 2026-06-30 | |
| ZURA | ZURA BIO LTD | 5.86% | 4.22M | $24.9M | +0.00%(+0) | $7.23(-23.00%) | 2026-06-30 | |
| ALMS | ALUMIS INC | 5.68% | 856.1K | $24.1M | +0.00%(+0) | $15.90(+59.23%) | 2026-06-30 | |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 4.79% | 274.4K | $20.3M | +0.00%(+0) | $60.68(+37.62%) | 2026-06-30 | |
| DFTX | DEFINIUM THERAPEUTICS INC | 4.71% | 425.0K | $20.0M | new | $32.27(+32.10%) | 2026-06-30 | |
| ANNX | ANNEXON INC | 4.71% | 3.50M | $20.0M | +40.00%(+1.00M) | $5.30(-0.11%) | 2026-06-30 | |
| ORKA | ORUKA THERAPEUTICS INC | 4.11% | 183.3K | $17.4M | +0.00%(+0) | $35.23(+219.26%) | 2026-06-30 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 3.93% | 855.8K | $16.7M | +71.16%(+355.81K) | $16.86(-1.97%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +26.96% | +104.65% | +7.74% | +45.18% |
| Top 20 Holdings Unweighted | +32.22% | +131.15% | +11.95% | +75.86% |
Great Point Partners LLC reports $529.12M in US-listed equity holdings across 37 positions in its most recent 13F filing. Its largest disclosed positions are VOR (7.4%), ABVX (6.4%) and VERA (6.1%). The top 20 holdings account for 81.73% of reported assets. Its disclosed equity book has returned +104.65% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Great Point Partners LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Great Point Partners LLCโs Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1281446). View Great Point Partners LLCโs 13F filings on SEC